Four Strategies For Reducing Ridiculously Inflated Drug Prices

Four Strategies For Reducing Ridiculously Inflated Drug Prices

American consumers pay hundreds of billion of dollars in inflated pharmaceutical prices because drug companies are legal monopolies, a result of current patent laws. Dean Baker of the Center for Economic and Policy Research evaluates 4 separate strategies for slashing the cost of drugs and seeing drugs as a common good.

Facebooktwitterredditmail
David Morris
Follow David Morris:
David Morris

David Morris is co-founder of the Institute for Local Self-Reliance. His five non-fiction books range from an analysis of Chilean development to the future of electric power to the transformation of cities and neighborhoods.  For 14 years he was a regular columnist for the Saint Paul Pioneer Press. His essays on public policy have appeared in the New York TimesWall Street Journal, Washington PostSalonAlternetCommon Dreams, and the Huffington Post.